Tag: MindImmune Therapeutics Inc.
A HIGH-STAKES VENTURE: Slater startup fund has placed bets on 140...
Rhode Island’s old industrial base had already been decimated by the mid-1990s when state leaders scrambled to find ways to reinvent and revive the...
Could the state’s life science effort stall at the finish line?
Gov. Daniel J. McKee recently celebrated the $81.7 million opening of the new Ocean State Labs in Providence’s Jewelry District. The labs are a...
Ocean State Labs puts open layout to the test
As Rhode Island’s life sciences industry continues to take shape, John Flavin wants the state’s first incubator wet lab space to feel different from...
Five Questions With: Stevin Zorn
Stevin Zorn is CEO, president and co-founder of MindImmune Therapeutics Inc., a drug discovery company launched to develop new treatments for Alzheimer’s and other central...
State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience
For the developers of Pointz, a navigation app geared toward safer routes for cyclists, Rhode Island offered a wealth of mentoring and networking opportunities,...
MindImmune Therapeutics closes $500K seed round led by Slater Fund
PROVIDENCE – MindImmune Therapeutics Inc., a pharmaceutical startup, closed its second seed round of $500,000 on Monday.
The round was led by a $250,000 investment...
- Featured Event -
